NIH-funded research R21 grant

Investigating how a specific brain region affects anxiety and stress responses

Official title: Intrinsic CRF signaling within the lateral habenula

Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-10799660 · Data updated 2026-11-12

This study is looking at how certain brain signals affect anxiety and depression, using mice to see how different brain cells work in both male and female mice, which could help us find better treatments for anxiety disorders.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med
NIH-funded
Lab location1 site (Bethesda, United States)
Project startMarch 2, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$189,828
NIH project number5R21MH132136-02
Project IDNIH-10799660 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals experiencing anxiety disorders or related mental health issues.

Less likely to help

Patients with anxiety disorders that are not influenced by CRF signaling or those with other unrelated psychiatric conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of corticotropin-releasing factor (CRF) signaling in the lateral habenula, a brain region involved in regulating anxiety and depression. By using advanced techniques such as mouse genetics and optogenetics, the study aims to explore how specific neurons in this area influence behaviors related to anxiety in both male and female mice. The research will help identify the mechanisms behind stress responses and how they may differ between sexes, potentially leading to targeted treatments for anxiety disorders.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating anxiety and depression, particularly in vulnerable populations.

How similar studies have gone: Previous research has shown promising results in understanding CRF signaling in anxiety, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Henry M. Jackson Fdn for the Adv Mil/med
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Nugent, Fereshteh S — Henry M. Jackson Fdn for the Adv Mil/med
  • Study coordinator: Nugent, Fereshteh S

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.